Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1999-4-21
pubmed:abstractText
While meropenem MICs were strongly influenced by the presence or absence of the MexAB-OprM efflux pump in both OprD-proficient and -deficient strain backgrounds, MICs of imipenem and of ER-35786 remained unchanged, demonstrating that meropenem is a substrate of MexAB-OprM but not imipenem and ER-35786. In vitro, all three carbapenems selected loss of OprD as a first mechanism of resistance. However, in an OprD-deficient background, meropenem was able to select MexAB-OprM overproducers as a secondary resistance mechanism, while ER-35786 selected a mutant cross-resistant to sparfloxacin and cefpirome.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-1416876, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-2109575, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-408599, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-6803666, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-6813310, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-6943333, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-7562993, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-7600618, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-7726503, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-7793866, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-7986004, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-8153625, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-8226684, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-8540696, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-8585714, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-8830678, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-8849250, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-8878035, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-8983889, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-9044268, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-9182100, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-9371363, http://linkedlifedata.com/resource/pubmed/commentcorrection/9925552-9687387
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0066-4804
pubmed:author
pubmed:issnType
Print
pubmed:volume
43
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
424-7
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems.
pubmed:affiliation
Department of Genetics and Microbiology, Centre Médical Universitaire, Geneva 4, Switzerland. Thilo.Kohler@medecine.unige.ch
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't